Page 203 - BCML AR 2019-20
P. 203

BALRAMPUR CHINI MILLS LIMITED


            Notes forming part of the Standalone Financial Statements


             Note No. : 36 Other disclosures (contd.)

            The details of Options granted, lapsed and exercised as at 31st March, 2019 are as under :
             Particulars                                                         During year ended   Cumulative upto
                                                                                      31st March,     31st March,
                                                                                           2019            2019
             Year of  Issue                                                              2008-09
             Series                                                                     5th Series
             Date of grant of Option                                                  28/05/2009
             Initial exercise price (H)                                                    45.00
                                                                                                   Not Applicable
             Revised exercise price (H)                                              Not applicable
             Market price on the date of grant  (H)                                        82.35
             Excess of initial exercise price over revised exercise price (H)        Not applicable
             Excess of market price over exercise price/ revised exercise price (C)        37.35
             Options vested (Nos.)                                                            -         4593000
             Outstanding at the beginning of the year (Nos.)                              25500         5245500
             Granted (Nos.)                                                                    -               -
             Exercised (Nos.) *                                                                -        4422500
             Forfeited/Lapsed and expired (Nos.)                                          25500          823000
             Outstanding at the end of the year (Nos.)                                         -               -
             Exercisable at the end of the year (Nos.)                                         -               -
             Money realised on exercise of Options (H in Lacs)                                 -         2014.29
             * Includes 10,000 options which were exercised within 31st March, 2018 against which allotment of equity shares were made during the year
            ended 31st March, 2019.
            Total Number of Options outstanding/exercisable as at 1st April, 2018 relating to 1st, 2nd, 3rd and 4th series is Nil. Therefore, in the above
            table related information has been excluded under during the year ended 31st March 2019, however, included under cumulative upto 31st
            March 2019.
            Other information:
            (a)   Total number of equity shares arising as a result of exercise of Options as at 31st March, 2019 : 44,22,500
                Options equivalent to 10,000 equity shares were exercised during the year ended 31st March, 2018, however, equity shares against
                the Options exercised were allotted during the year ended 31st March, 2019.
            (b)   Details of Options granted to :-
                (i)   Senior Managerial Personnel: No Options have been granted during the year ended 31st March, 2019;
                (ii)   Any other employee who receives a grant in any one year of Options amounting to 5% or more of Options granted during year
                     ended 31st March, 2019 : Nil.
            4.   Based on the information/documents available with the Company,  information as per the requirement of section 22 of the Micro,
                Small and Medium Enterprises Development Act, 2006 with respect to trade payables and payable to suppliers of capital goods are as follows:














                                                                                          Annual Report 2019-20 | 201
   198   199   200   201   202   203   204   205   206   207   208